{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:21:30Z","timestamp":1790716890348,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"DOI":"10.7759\/cureus.85212","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T01:34:47Z","timestamp":1748828087000},"source":"Crossref","is-referenced-by-count":13,"title":["Poorly Regulated Antibiotic Use in Nigeria: A Critical Public Health Concern and Its Impact on Medical Practice"],"prefix":"10.7759","author":[{"given":"Olajide J","family":"Olagunju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbo","family":"Ben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olayinka","family":"Olagunju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwadamilola G","family":"Majolagbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olagoke O","family":"Osanyinlusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titilade","family":"Adewoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omolola F","family":"Atoyebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iyanuloluwa O","family":"Ojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam D","family":"Dawha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ph16111615","article-title":"Origin of antibiotics and antibiotic resistance, and their impacts on drug development: A narrative review","volume":"16","author":"Muteeb G","year":"2023","unstructured":"Muteeb G, Rehman MT, Shahwan M, Aatif M. Origin of antibiotics and antibiotic resistance, and their impacts on drug development: A narrative review. Pharmaceuticals (Basel). 2023, 16:1615. 10.3390\/ph16111615","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2021-002762","article-title":"Antimicrobial resistance in Nigeria: Challenges and charting the way forward","volume":"29","author":"Iheanacho CO","year":"2022","unstructured":"Iheanacho CO, Eze UI. Antimicrobial resistance in Nigeria: Challenges and charting the way forward. Eur J Hosp Pharm. 2022, 29:119. 10.1136\/ejhpharm-2021-002762","journal-title":"Eur J Hosp Pharm"},{"key":"ref3","unstructured":"Antibiotics Abuse in Nigeria. Ignorance or Sabotage?. (2023). Accessed: April 30, 2025: https:\/\/uimsapress.org\/antibiotics-abuse-in-nigeria-ignorance-or-sabotage\/."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2021.1951705","article-title":"Antimicrobial resistance in low- and middle-income countries: Current status and future directions","volume":"20","author":"Sulis G","year":"2022","unstructured":"Sulis G, Sayood S, Gandra S. Antimicrobial resistance in low- and middle-income countries: Current status and future directions. Expert Rev Anti Infect Ther. 2022, 20:147-60. 10.1080\/14787210.2021.1951705","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11131946","article-title":"Antimicrobial resistance: A growing serious threat for global public health","volume":"11","author":"Salam MA","year":"2023","unstructured":"Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA, Alqumber MA. Antimicrobial resistance: A growing serious threat for global public health. Healthcare (Basel). 2023, 11:1946. 10.3390\/healthcare11131946","journal-title":"Healthcare (Basel)"},{"key":"ref6","article-title":"Microbacterial profile of surgical site infection and their pattern of sensitivity in tertiary hospital in North Central Hospital, Nigeria","volume":"21","author":"Abiodun AA","year":"2023","unstructured":"Abiodun AA, Adekanye AO, Nwachukwu CND, Ayanbeku TS, Abiodun JA. Microbacterial profile of surgical site infection and their pattern of sensitivity in tertiary hospital in North Central Hospital, Nigeria. Ann Ib Postgrad Med. 2023, 21:30-5.","journal-title":"Ann Ib Postgrad Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.18683\/germs.2021.1287","article-title":"Antimicrobial use among hospitalized patients: A multi-center, point prevalence survey across public healthcare facilities, Osun State, Nigeria","volume":"11","author":"Aboderin AO","year":"2021","unstructured":"Aboderin AO, Adeyemo AT, Olayinka AA, et al.. Antimicrobial use among hospitalized patients: A multi-center, point prevalence survey across public healthcare facilities, Osun State, Nigeria. Germs. 2021, 11:523-35. 10.18683\/germs.2021.1287","journal-title":"Germs"},{"key":"ref8","unstructured":"Information, Insight and Intelligence on the Nigerian Health Sector. (2024). https.\/\/articles.nigeriahealthwatch.com\/world-uhc-day-2024-nigerias-government-must-ensure-equitable-healthcare-acces...."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-023-00629-x","article-title":"Antimicrobial stewardship: Knowledge, perceptions, and factors associated with antibiotics misuse among consumer's visiting the community pharmacies in a Nigeria Southwestern State","volume":"16","author":"Akande-Sholabi W","year":"2023","unstructured":"Akande-Sholabi W, Oyesiji E. Antimicrobial stewardship: Knowledge, perceptions, and factors associated with antibiotics misuse among consumer's visiting the community pharmacies in a Nigeria Southwestern State. J Pharm Policy Pract. 2023, 16:120. 10.1186\/s40545-023-00629-x","journal-title":"J Pharm Policy Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12982-024-00251-5","article-title":"Perception of antibiotic misuse and awareness of antibiotic resistance among adults in Delta State, Nigeria","volume":"21","author":"Enechukwu OH","year":"2024","unstructured":"Enechukwu OH, Saka MJ. Perception of antibiotic misuse and awareness of antibiotic resistance among adults in Delta State, Nigeria. Discov Public Health. 2024, 21:124. 10.1186\/s12982-024-00251-5","journal-title":"Discov Public Health"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.51594\/imsrj.v4i3.920","article-title":"Enhancing medication quality control in Nigeria: A comprehensive analysis of regulatory challenges and solutions","volume":"4","author":"Eruaga MA","year":"2024","unstructured":"Eruaga MA, Itua EO, Bature JT. Enhancing medication quality control in Nigeria: A comprehensive analysis of regulatory challenges and solutions. Int Med Sci Res J. 2024, 4:284-94. 10.51594\/imsrj.v4i3.920","journal-title":"Int Med Sci Res J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.9790\/0837-2504061118","article-title":"Challenges and opportunities of pharmaceutical regulation in Nigeria","volume":"25","author":"Usar IJ","year":"2020","unstructured":"Usar IJ, Bukar BB. Challenges and opportunities of pharmaceutical regulation in Nigeria. IOSR J Humanit Soc Sci. 2020, 25:11-8. 10.9790\/0837-2504061118","journal-title":"IOSR J Humanit Soc Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.82381","article-title":"Pregnancy monitoring in Potiskum and neighboring communities of Yobe State, Nigeria: Challenges and maternal health implications in rural settings","volume":"17","author":"Olagunju OJ","year":"2025","unstructured":"Olagunju OJ, Ben E, Olagunju O, Majolagbe OG, Osanyinlusi OO, Adewoye TO, Atoyebi OF. Pregnancy monitoring in Potiskum and neighboring communities of Yobe State, Nigeria: Challenges and maternal health implications in rural settings. Cureus. 2025, 17:e82381. 10.7759\/cureus.82381","journal-title":"Cureus"},{"key":"ref14","article-title":"Barriers to healthcare access in low-income countries and marginalized communities","volume":"5","author":"Goel A","year":"2024","unstructured":"Goel A, Goel P. Barriers to healthcare access in low-income countries and marginalized communities. Int J Res Publ Rev. 2024, 5:1049-54.","journal-title":"Int J Res Publ Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12909-025-07145-3","article-title":"Antibiotic use among university students: Insights from a Nigerian institution","volume":"25","author":"Onukansi FO","year":"2025","unstructured":"Onukansi FO, Umoh ME, Eneh SC, et al.. Antibiotic use among university students: Insights from a Nigerian institution. BMC Med Educ. 2025, 25:644. 10.1186\/s12909-025-07145-3","journal-title":"BMC Med Educ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.22178\/pos.115-25","article-title":"Fighting resistance with data: Leveraging digital surveillance to address antibiotic misuse in Nigeria","volume":"11","author":"Lawal OP","year":"2025","unstructured":"Lawal OP, Egwuatu EC, Akanbi KO, et al.. Fighting resistance with data: Leveraging digital surveillance to address antibiotic misuse in Nigeria. Path Sci. 2025, 11:1009-17. 10.22178\/pos.115-25","journal-title":"Path Sci"},{"key":"ref17","unstructured":"Nigeria Bolsters Laboratory Capacity for Antimicrobial Resistance Towards Universal Health Coverage. (2022). https.\/\/www.afro.who.int\/countries\/nigeria\/news\/nigeria-bolsters-laboratory-capacity-antimicrobial-resistance-towards...."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.07.010","article-title":"Antimicrobial resistance: A concise update","volume":"6","author":"Ho CS","year":"2025","unstructured":"Ho CS, Wong CT, Aung TT, et al.. Antimicrobial resistance: A concise update. Lancet Microbe. 2025, 6:100947. 10.1016\/j.lanmic.2024.07.010","journal-title":"Lancet Microbe"},{"key":"ref19","unstructured":"What I've Learnt From a Decade of Campaigning on Superbugs - Dame Sally Davies. (2024). https.\/\/www.weforum.org\/stories\/2024\/08\/antimicrobial-resistance-superbugs-antibiotics."},{"key":"ref20","unstructured":"Antimicrobial Resistance Facts and Stats. (2025). https.\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/facts-stats\/index.html."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.onehlt.2025.101053","article-title":"A review of antimicrobial resistance challenges in Nigeria: The need for a one health approach","volume":"20","author":"Alabi ED","year":"2025","unstructured":"Alabi ED, Rabiu AG, Adesoji AT. A review of antimicrobial resistance challenges in Nigeria: The need for a one health approach. One Health. 2025, 20:101053. 10.1016\/j.onehlt.2025.101053","journal-title":"One Health"},{"key":"ref22","unstructured":"Antimicrobial Use and Resistance in Nigeria. Situation Analysis and Recommendations. (2017). https:\/\/ncdc.gov.ng\/themes\/common\/docs\/protocols\/56_1510840387.pdf."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4102\/ajlm.v13i1.2268","article-title":"Antimicrobial resistance trends in clinical Escherichia coli and Klebsiella pneumoniae in Ethiopia","volume":"13","author":"Kitaba AA","year":"2024","unstructured":"Kitaba AA, Bonger ZT, Beyene D, et al.. Antimicrobial resistance trends in clinical Escherichia coli and Klebsiella pneumoniae in Ethiopia. Afr J Lab Med. 2024, 13:2268. 10.4102\/ajlm.v13i1.2268","journal-title":"Afr J Lab Med"},{"key":"ref24","unstructured":"Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report. (2021). https.\/\/iris.who.int\/bitstream\/handle\/10665\/341666\/9789240027336-eng.pdf."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: A systematic analysis with forecasts to 2050","volume":"404","author":"GBD 2021 Antimicrobial Resistance Collaborators","year":"2024","unstructured":"GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990-2021: A systematic analysis with forecasts to 2050. Lancet. 2024, 404:1199-226. 10.1016\/S0140-6736(24)01867-1","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-025-00860-4","article-title":"Antibiotic use and misuse in maritime settings: Challenges and implications for global antimicrobial resistance response","volume":"27","author":"Shao L","year":"2025","unstructured":"Shao L, Adebisi YA, Adeola QA. Antibiotic use and misuse in maritime settings: Challenges and implications for global antimicrobial resistance response. Curr Infect Dis Rep. 2025, 27:11. 10.1007\/s11908-025-00860-4","journal-title":"Curr Infect Dis Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32021-9","article-title":"Massive misuse of antibiotics by university students in China: A cross-sectional survey","volume":"388","author":"Wang XM","year":"2016","unstructured":"Wang XM, Zhou XD, Hesketh T. Massive misuse of antibiotics by university students in China: A cross-sectional survey. Lancet. 2016, 388:S94. 10.1016\/S0140-6736(16)32021-9","journal-title":"Lancet"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.artd.2022.05.014","article-title":"Bacteremia in patients undergoing debridement, antibiotics, and implant retention leads to increased reinfections and costs","volume":"16","author":"Rosas S","year":"2022","unstructured":"Rosas S, Hegde V, Plate FJ, Dennis D, Jennings J, Bracey DN. Bacteremia in patients undergoing debridement, antibiotics, and implant retention leads to increased reinfections and costs. Arthroplast Today. 2022, 16:259-263.e1. 10.1016\/j.artd.2022.05.014","journal-title":"Arthroplast Today"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255206","article-title":"Determinants and perception of health insurance participation among healthcare providers in Nigeria: A mixed-methods study","volume":"16","author":"Shobiye HO","year":"2021","unstructured":"Shobiye HO, Dada I, Ndili N, Zamba E, Feeley F, de Wit TR. Determinants and perception of health insurance participation among healthcare providers in Nigeria: A mixed-methods study. PLoS One. 2021, 16:e0255206. 10.1371\/journal.pone.0255206","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12893-024-02695-7","article-title":"Global surgery is stronger when infection prevention and control is incorporated: A commentary and review of the surgical infection landscape","volume":"24","author":"Hinson C","year":"2024","unstructured":"Hinson C, Kilpatrick C, Rasa K, Ren J, Nthumba P, Sawyer R, Ameh E. Global surgery is stronger when infection prevention and control is incorporated: A commentary and review of the surgical infection landscape. BMC Surg. 2024, 24:397. 10.1186\/s12893-024-02695-7","journal-title":"BMC Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/372929-poorly-regulated-antibiotic-use-in-nigeria-a-critical-public-health-concern-and-its-impact-on-medical-practice","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T01:34:51Z","timestamp":1748828091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/372929-poorly-regulated-antibiotic-use-in-nigeria-a-critical-public-health-concern-and-its-impact-on-medical-practice"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.85212","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,1]]}}}